Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
"White Mouse in Water" - Infinitus Develops New Technology of Using Zebrafish for Health Products Screening 2020-07-28 20:00
New Licensing Agreement Accelerates the Development of IACTA Pharmaceuticals' Novel Dry Eye Disease and Allergic Conjunctivitis Treatments in China and Southeast Asia 2020-07-28 17:59
AGC to Complete the Acquisition of MolMed on July 31, 2020 2020-07-28 10:00
Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA 2020-07-27 07:00
N.B. Quadriga's Transformative Treatment for Brain Cancers Dosed in First Human Subject 2020-07-23 19:00
Zhongchao Inc. Joined Hands with Professional Non-Profit Organizations and 9 Leading Pharma Companies to Carry Out Multi-Year Online Education Project on Diagnosis and Treatment of Primary Liver Cancer 2020-07-23 18:30
Ascentage Pharma Announces First Patient Dosed in the Phase Ib Study of MDM2-p53 Inhibitor APG-115 as Single Agent and in Combinations for the Treatment of Hematologic Malignancies in China 2020-07-22 17:31
China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor 2020-07-20 22:39
JW Therapeutics Acquires Syracuse Biopharma and Its in-Licenses With Eureka Therapeutics' Solid Tumor Technologies in China 2020-07-20 21:33
Connect Biopharma Initiates Phase 2 Clinical Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis 2020-07-20 20:00
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization 2020-07-20 08:00
Harbour BioMed Presented Pre-Clinical Data on A Fully Human Anti-CD73 Antibody at AACR Virtual Annual Meeting 2020-07-16 18:00
Ascentage Pharma's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Designation by the FDA for the Treatment of Waldenström Macroglobulinemia 2020-07-15 21:07
Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia 2020-07-14 18:00
Zuellig Pharma appoints John Graham as new CEO 2020-07-14 09:00
Frost & Sullivan Reveals Technological Advances Facilitating Research across Preclinical Disease Models 2020-07-14 01:55
PQE Group Creates an Internal Research Task Force to Fight Fake News in Relation to COVID-19 2020-07-13 16:00
AVATAMED Partners CBmed in Europe on Precision Cancer Project 2020-07-13 15:16
SINOMED® Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent 2020-07-13 15:00
Sales of Cardio-Cerebrovascular Products and Lianhua Qingwen Surge, Yiling Pharmaceutical Predicting a 50% Increase in Half-year Net Profit 2020-07-13 12:25
1 151 152 153 154 155 230